2-(5-Methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)acetic acid → HCID 21092773, compound

HRID 1348976Notes

Reaction equation

HRID 1348976 reaction equation
[CH2:1]([O:3][C:4](=[O:27])[CH2:5][NH:6][CH2:7][CH2:8][NH:9][S:10]([C:13]1[S:14][C:15]([C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][C:19]=2[N+:24]([O-:26])=[O:25])=[N:16][N:17]=1)(=[O:12])=[O:11])[CH3:2].[N:28]1([CH2:37][C:38](O)=[O:39])[CH:36]=[C:34]([CH3:35])[C:32](=[O:33])[NH:31][C:29]1=[O:30]>>[CH2:1]([O:3][C:4](=[O:27])[CH2:5][N:6]([CH2:7][CH2:8][NH:9][S:10]([C:13]1[S:14][C:15]([C:18]2[CH:23]=[CH:22][CH:21]=[CH:20][C:19]=2[N+:24]([O-:26])=[O:25])=[N:16][N:17]=1)(=[O:12])=[O:11])[C:38](=[O:39])[CH2:37][N:28]1[CH:36]=[C:34]([CH3:35])[C:32](=[O:33])[NH:31][C:29]1=[O:30])[CH3:2]

Participants

3

Reactant 2

HCID 8537532-(5-Methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)acetic acidHCID 21092771HCID 21092771, compound

Product 1

HCID 21092773HCID 21092773, compound

Procedure

The title compound was synthesized by the reaction of N-{2-[5-(2-nitrophenyl)-1,3,4-thiadiazole-2-sulfonylamino]-ethyl}-glycine ethyl ester with (thymin-1-yl)-acetic acid as per the procedure of example 13. 1H NMR (400 MHz; DMSO-d6) δ 11.29 (s, 0.6H), 11.28 (s, 0.4H), 9.21 (brs, 0.6H), 9.10 (brs, 0.4H), 8.26–8.21 (m, 1H), 7.97–7.89 (m, 3H), 7.33 (d, 0.6H), 7.26 (d, 0.4H), 4.68 (s, 1.2H), 4.45 (s, 0.4H), 4.33 (s, 0.8H), 4.18 (q, 0.8H), 4.08 (q, 1.2H), 4.07 (s, 1.2H), 3.59 (t, 1.2H), 3.47–3.40 (m, 2H), 3.28 (t, 0.8H), 1.74 (s, 3H), 1.24 (t, 1.2H), 1.18 (t, 1.8H).

Sources & evidence

ORD record
ord-29e2fd3631e94b9bb17a327f8753109f
Source dataset
uspto-grants-2007_05
Patent number
US07211668B2

Reaction notes

Loading…